Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

28 Jun 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached a press release today titled ‘Glenmark Pharmaceuticals Inc., USA continues to expand its Over-The-Counter (OTC) Portfolio with the acquisition of approved ANDAs from Wockhardt Limited’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..